Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Research programme: DNA vaccines - Inovio

Next Previous
Drug Profile

Research programme: DNA vaccines - Inovio

Alternative Names: Chikungunya virus DNA vaccine - Inovio; CHIKV vaccine - Inovio; Cytomegalovirus DNA vaccine - Inovio; dMab HIV - Inovio; DNA vaccine against HIV clade C - Inovio; INO 5400; MAGE-A DNA vaccine; Malaria vaccine - Inovio; Prostate-cancer DNA vaccines - Inovio; Smallpox vaccine - Inovio; SynCon WT1 cancer immunotherapy

Latest Information Update: 28 May 2025

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Inovio Pharmaceuticals
  • Developer Drexel University College of Medicine; Inovio Pharmaceuticals; Walter Reed Army Institute of Research; Wistar Institute
  • Class AIDS vaccines; Bacterial vaccines; Cancer vaccines; DNA vaccines; Hepatitis C vaccines; Parasitic vaccines; Synthetic vaccines; Viral vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No
  • Available For Licensing Yes - Smallpox

Highest Development Phases

  • No development reported Prostate cancer
  • Discontinued Cancer; Chikungunya virus infections; Clostridium difficile infections; Cytomegalovirus infections; Human papillomavirus infections; Malaria; Malignant melanoma; Smallpox; Tuberculosis

Most Recent Events

  • 28 May 2025 No recent reports of development identified for preclinical development in Prostate-cancer in USA (Parenteral)
  • 10 Apr 2021 Preclinical trials in Prostate cancer in USA (Parenteral) prior to April 2021
  • 10 Apr 2021 Pharmacodynamics data from preclinical studies in prostate cancer presented at the 112th Annual Meeting of the American Association for Cancer Research (AACR-2021)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top